acut
respiratori
infect
frequent
transmit
ill
concern
doctor
patient
consid
airborn
transmiss
earli
diagnosi
diseas
particularli
import
studi
explor
respiratori
viral
infect
influenza
viru
parainfluenza
viru
respiratori
syncyti
viru
human
metapneumoviru
human
bocaviru
coronaviru
earli
diagnost
substanc
confirm
literatur
resourc
studi
also
use
correspond
monoclon
antibodi
produc
use
hybridoma
technolog
fix
chip
purif
serum
detect
use
method
new
techniqu
simultan
detect
kind
febril
respiratori
virus
protein
chip
develop
accuraci
rate
method
product
inexpens
capabl
highprecis
highthroughput
screen
promin
advantag
cute
respiratori
infect
ari
account
larg
proport
acut
morbid
develop
countri
major
infect
viral
etiolog
acut
viral
respiratori
tract
infect
lead
caus
hospit
infant
young
children
develop
countri
major
caus
death
develop
countri
develop
countri
number
viral
respiratori
episod
per
year
estim
children
school
age
versu
age
ari
repres
caus
hospit
admiss
categori
patient
respiratori
tract
infect
lead
acut
asthma
exacerb
acut
otiti
media
lower
respiratori
tract
present
includ
bronchiti
bronchiol
pneumonia
wide
rang
pathogen
involv
ari
includ
bacteria
virus
clinic
practic
specif
viru
often
identifi
owe
lack
avail
sensit
test
presenc
yet
unidentifi
pathogen
failur
use
appropri
test
major
caus
ari
children
adult
influenza
virus
b
c
parainfluenza
viru
piv
type
adenoviru
respiratori
syncyti
viru
rsv
rhinoviru
past
decad
sever
new
respiratori
virus
includ
avian
influenza
virus
human
metapneumoviru
hmpv
human
bocaviru
hbov
sever
acut
respiratori
syndrom
coronaviru
sar
cov
human
coronavirus
hcov
polyomaviru
wuki
parvoviru
mimiviru
swineorigin
pandem
influenza
hemagglutinin
type
protein
neuraminidas
type
emerg
recogn
caus
upper
respiratori
tract
infect
lower
respiratori
tract
infect
clinic
import
newli
discov
virus
current
investig
clear
rhinovirus
coronavirus
thought
caus
common
cold
infect
respiratori
tract
case
may
caus
fatal
virus
mention
caus
upper
lower
tract
infect
overlap
clinic
present
physician
usual
distinguish
caus
agent
without
laboratori
diagnosi
convent
method
viral
diagnosi
includ
cytolog
immunolog
molecular
biolog
detect
limit
abil
isol
limit
rang
virus
caus
respiratori
diseas
restrict
rang
virus
diagnos
rapidli
use
antigen
detect
howev
given
high
cost
test
complex
oper
long
cycl
high
requir
equip
oper
factor
technolog
significantli
limit
applic
rapid
diagnosi
respiratori
viral
infect
particularli
earli
diagnosi
decis
role
develop
rapid
accur
treatment
program
nucleic
acid
amplif
test
nat
recogn
play
import
role
diagnos
respiratori
viru
infect
sinc
emerg
cov
showcas
import
test
diagnos
respiratori
viru
infect
nat
develop
respiratori
virus
includ
convent
emerg
virus
protein
microarray
develop
limit
use
dna
microarray
determin
gene
express
level
proteom
quantiti
mrna
cell
often
reflect
express
level
protein
correspond
usual
protein
rather
mrna
function
role
cell
respons
novel
approach
need
addit
posttransl
modif
often
critic
determin
protein
function
visibl
dna
microarray
protein
microarray
replac
tradit
proteom
techniqu
gel
electrophoresi
chromatographi
time
consum
laborintens
illsuit
analysi
lowabund
protein
among
respiratori
viral
infect
influenza
viru
piv
rsv
hmpv
hbov
cov
caus
sever
acut
respiratori
syndrom
becom
exceedingli
common
object
present
studi
identifi
earli
diagnost
substanc
kind
respiratori
virus
prepar
monoclon
antibodi
develop
correspond
protein
chip
rapid
diagnost
kit
given
simpl
viru
structur
viru
antigen
determin
gener
focus
genet
materi
protein
particularli
nucleocapsid
protein
strong
speciesspecif
pattern
therefor
nucleocapsid
protein
good
marker
earli
diagnosi
base
literatur
present
studi
identifi
earli
diagnost
marker
virus
influenza
viru
b
sixto
femal
balbc
mice
use
experi
anim
vaccin
screen
hybridoma
accord
convent
method
balbc
mice
immun
antigen
protein
collect
use
freund
complet
adjuv
mgmice
fusion
spleen
cell
cell
mice
detect
indirect
enzymelink
immunosorb
assay
elisa
use
screen
hybridoma
cell
secret
posit
antibodi
phalanx
titrat
method
use
determin
viabl
antigen
protein
concentr
clone
posit
screen
hybridoma
cell
clone
subclon
posit
hole
repeat
final
high
valu
select
well
goodcel
viabil
singlehol
cell
line
cultur
prolifer
clone
purif
posit
cell
line
posit
hybridoma
cell
line
clone
purifi
posit
clone
hole
use
convent
method
clone
cell
hole
posit
hemagglutin
inhibit
hi
test
hybridoma
cell
line
receiv
continu
passag
gener
use
indirect
elisa
determin
cell
supern
titer
hybridoma
cell
line
screen
stabil
antibodi
secret
titer
monoclon
antibodi
ascit
measur
mean
indirect
elisa
hi
test
monoclon
antibodi
subtyp
detect
sba
clonotyp
systemhrp
antibodi
subtyp
identif
kit
antibodi
specif
identifi
use
western
blot
microhol
plate
place
vacuum
filtrat
apparatu
ml
methanol
concentr
ad
hole
sampl
incub
room
temperatur
second
filtrat
devic
set
low
vacuum
hole
rins
ml
ultrapur
water
twice
activ
determin
optim
concentr
dilut
antibodi
protein
detect
well
rais
activ
microhol
plate
nl
antibodi
protein
spray
use
tini
sprayer
much
like
found
inkjet
printer
smartarray
biorad
usa
hole
microarray
sampl
quickli
place
microhol
plate
wet
box
c
fix
hour
slide
remov
hydrat
wash
thrice
phosphatebuff
salin
solut
tween
pbst
minut
time
dri
c
place
seal
bag
preserv
c
collect
patient
influenza
viru
infect
piv
infect
rsv
infect
hmpv
infect
hbovinfect
patient
covinfect
patient
healthi
control
subject
depart
clinic
laboratori
guangzhou
center
diseas
control
prevent
peopl
republ
china
evalu
rapid
antigen
test
diagnosi
respiratori
viral
pathogen
patient
affirm
singl
viru
infect
use
convent
respiratori
viru
detect
method
normal
control
subject
diagnos
without
kind
respiratori
infect
written
inform
consent
conform
tenet
declar
helsinki
obtain
particip
studi
institut
review
board
guangzhou
center
diseas
control
prevent
approv
studi
ml
obtain
serum
sampl
ad
ml
sampl
diluent
contain
goat
antiehuman
igg
incub
minut
neutral
igg
ml
dilut
serum
ad
detect
hole
incub
hour
c
chip
wash
pbst
thrice
minut
time
approxim
ml
horseradish
peroxidas
hrp
elabel
mous
antiehuman
igm
monoclon
antibodi
ad
sampl
incub
hour
c
chip
wash
pbst
thrice
minut
time
ml
tetramethylbenzidin
tmb
chromogen
reagent
ad
hole
kept
chromogen
minut
c
result
record
visual
use
digit
camera
scanner
signal
detect
consid
posit
receiv
oper
characterist
roc
curv
fundament
tool
diagnost
test
evalu
roc
curv
true
posit
rate
sensit
plot
function
fals
posit
rate
specif
differ
cutoff
point
paramet
point
roc
curv
repres
sensitivityspecif
pair
correspond
particular
decis
threshold
area
roc
curv
auc
measur
well
paramet
distinguish
diagnost
group
diseas
normal
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
cellular
porin
chip
kit
calcul
serum
chip
reveal
content
influenza
viru
piv
rsv
hmpv
bov
cov
serum
microarray
microhol
distribut
type
viru
antibodi
shown
fig
part
microhol
plate
test
result
shown
fig
indic
crossinflu
among
result
roc
curv
patient
acut
respiratori
infect
compar
patient
without
respiratori
infect
plot
auc
protein
chip
detect
influenza
viru
ci
p
piv
ci
p
rsv
ci
p
hmpv
ci
p
bov
ci
p
cov
ci
p
respect
sensit
specif
ppv
npv
diagnost
accuraci
acut
respiratori
viru
calcul
accord
roc
list
tabl
diagnosi
ari
reli
clinic
examin
radiolog
explor
biolog
nonspecif
inflammatori
test
includ
level
creactiv
protein
procalcitonin
identif
caus
agent
often
omit
limit
pathogen
easi
detect
rapid
antigen
direct
test
influenza
virus
rsv
respiratori
specimen
streptococcu
pneumonia
legionella
pneumophila
urin
specimen
howev
distinct
viral
bacteri
infect
often
imposs
use
nonmicrobiolog
criteria
need
precis
rapid
identif
caus
agent
ari
recent
review
main
advantag
strategi
better
use
antimicrobi
includ
antivir
drug
antibiot
thu
limit
develop
bacteri
resist
reduct
unnecessari
paraclin
explor
durat
hospit
rapid
implement
isol
measur
necessari
thu
limit
risk
nosocomi
transmiss
collect
real
time
new
epidemiolog
data
season
spread
pathogen
identif
simultan
success
infect
may
justifi
specif
intervent
explain
sever
clinic
pictur
protein
chip
recogn
play
import
role
diagnos
respiratori
viru
infect
protein
chip
highthroughput
method
use
track
interact
activ
protein
determin
function
includ
larg
scale
main
advantag
lie
fact
larg
number
protein
track
parallel
chip
consist
support
surfac
glass
slide
nitrocellulos
membran
bead
microtit
plate
array
captur
protein
bound
probe
molecul
typic
label
fluoresc
dye
ad
array
reaction
probe
immobil
protein
emit
fluoresc
signal
read
laser
scanner
protein
microarray
rapid
autom
econom
highli
sensit
consum
small
quantiti
sampl
reagent
concept
methodolog
protein
microarray
first
introduc
illustr
antibodi
microarray
also
refer
antibodi
matrix
scientif
public
seri
patent
highthroughput
technolog
behind
protein
microarray
rel
easi
develop
base
technolog
develop
dna
microarray
becom
wide
use
microarray
protein
array
detect
method
must
give
high
signal
low
background
common
wide
use
method
detect
fluoresc
label
highli
sensit
safe
compat
readili
avail
microarray
laser
scanner
label
use
affin
photochem
radioisotop
tag
label
attach
probe
interfer
probetarget
protein
reaction
therefor
number
labelfre
detect
method
avail
surfac
plasmon
reson
carbon
nanotub
carbon
nanowir
sensor
detect
occur
via
chang
conduct
microelectromechan
system
cantilev
labelfre
detect
method
rel
new
yet
suitabl
highthroughput
protein
interact
detect
howev
offer
much
promis
futur
protein
chip
wide
use
rapid
detect
variou
diseas
establish
certain
foundat
earli
detect
febril
respiratori
diseas
present
studi
fix
earli
marker
correspond
febril
respiratori
viru
antibodi
antibodi
chip
detect
mean
fix
antibodi
specif
recognit
earli
viru
marker
found
human
serum
result
show
specif
select
antibodi
earli
marker
extrem
strong
posit
rate
piv
rsv
bov
undetect
case
probabl
experiment
oper
oper
factor
howev
overal
posit
detect
rate
meet
requir
standard
rapiddetect
chip
consist
accuraci
compar
elisa
method
chip
extrem
use
rapid
detect
kind
viral
infect
earli
stage
